M
Mario Boccadoro
Researcher at University of Turin
Publications - 670
Citations - 39049
Mario Boccadoro is an academic researcher from University of Turin. The author has contributed to research in topics: Multiple myeloma & Lenalidomide. The author has an hindex of 83, co-authored 638 publications receiving 34589 citations. Previous affiliations of Mario Boccadoro include Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
Elena Zamagni,Stefania Oliva,Francesca Gay,Andrea Capra,Delia Rota Scalabrini,Mattia D'Agostino,Angelo Belotti,Monica Galli,Manuela Racca,Renato Zambello,Barbara Gamberi,Domenico Albano,L. Bertamini,Annibale Versari,Mariella Grasso,Nicola Sgherza,Claudia Priola,Francesca Fioritoni,Francesca Patriarca,Gabriella De Cicco,Tania Villanova,Anna Pascarella,Pietro Zucchetta,Paola Tacchetti,Stefano Fanti,Katia Mancuso,Simona Barbato,Mario Boccadoro,Pellegrino Musto,Michele Cavo,Cristina Nanni +30 more
TL;DR: In this article , the role of CMR and its complementarity with BM multiparameter flow cytometry (MFC) at 10-5, in an independent cohort of newly diagnosed transplant-eligible multiple myeloma (MM) patients previously enrolled in the phase II randomised FORTE trial was confirmed.
Journal Article
Allogenic stem cell transplantation following non-myeloablative conditioning regimens as adoptive immunotherapy in patients with hematological malignancies.
TL;DR: Preliminary results are encouraging and demonstrate the feasibility of non-myeloablative transplants in patients with heterogeneous diseases and disease status who Current challenges include defining the optimal regimen to promote full donor engraftment and the malignancies susceptible to this approach.
Journal ArticleDOI
Identification of a new allele, HLA-DRB5*0113, through three different molecular biology techniques.
Elena Garino,M. Berrino,Francesca Bertinetto,P. Caropreso,R. Chidichimo,Ennia Dametto,M. E. Fasano,Elisa Frisaldi,Gina Mazzola,Fabrizio Tondat,Mario Boccadoro,Benedetto Bruno,Antonio Amoroso +12 more
TL;DR: A new HLA-DRB5 allele has been identified in an Italian patient during routine HLA typing in order to activate a bone marrow donor search, and the results showed that the HLAs differ for three nucleotide substitutions at codons 57 and 58.
Journal ArticleDOI
Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (GEN503): Final Results of an Open-Label, Phase 1/2 Study
Torben Plesner,Hendrik-Tobias Arkenau,Monique C. Minnema,Mario Boccadoro,Philippe Moreau,James D. Cavenagh,Aurore Perrot,Jacob P. Laubach,Tahamtan Ahmadi,Carla de Boer,Diana Chen,Christopher Chiu,Jordan M. Schecter,Paul G. Richardson +13 more
TL;DR: The final safety and efficacy results of the GEN503 study of DARA in combination with lenalidomide and dexamethasone with approximately 3-year follow-up in patients with RRMM are provided.
Journal ArticleDOI
Analysis of Transcriptome, Mirnome and Genomic Profiles in Association with Clinical Outcome in a Prospective Series of Primary Plasma Cell Leukemia
Luca Agnelli,Pellegrino Musto,Katia Todoerti,Marta Lionetti,Laura Mosca,Sonia Fabris,Giacomo Tuana,Marzia Barbieri,Vitina Grieco,Gabriella Bianchino,Fiorella D'Auria,Teodora Statuto,Carmela Mazzoccoli,Luciana De Luca,Maria Teresa Petrucci,Fortunato Morabito,Massimo Offidani,Francesco Di Raimondo,Antonietta Falcone,Paola Omedè,Mario Boccadoro,Antonio Palumbo,Antonino Neri +22 more
TL;DR: Overall, this study represents the first integrated approach on a prospective study investigating genes and miRNAs expression and genotyping configuration in PPCL, indicating specific genes andmiRNAs with relevance in the clinical outcome of the disease.